Elected by a body of fellow immunotherapy researchers from across the globe, Roswell Park Comprehensive Cancer Center Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, has been named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors. The nonprofit organization’s members voted for Dr. Odunsi during their election in May. He will begin his three-year term in January 2021.

Roswell Park Comprehensive Cancer Center staff and patients are mourning a devastating loss. Oscar Colegio, MD, PhD, the Lawrence P. & Joan Castellani Family Endowed Chair in Dermatology at the Buffalo-based cancer center, died unexpectedly this weekend at a family residence in Connecticut.

New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center’s Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow transplant (BMT) — a potentially curative treatment for selected patients with hematologic disorders — can be decreased using an existing class of drugs called beta adrenergic agonists.

Whether it is pioneering lab research or developing new procedures and treatments, innovation thrives at Roswell Park Comprehensive Cancer Center. Department of Urology surgeon Eric Kauffman, MD, was recognized for his novel approach for prostate cancer surgery by the American Urological Association (AUA), receiving a Best Video award for 2020.